We dont have a definitive answer yet, but heres what we do know: Using GLP-1s for at least 12 months improves outcomes Stopping often leads to weight regain
Browse all Peptides and GLP-1 education Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
About 10 percent of people on the highest orforglipron dose stopped the study because of side effects, compared with 2.6 percent of people on the placebo pill
Studies suggest that MC1R signaling may influence nucleotide excision repair pathways independently of pigmentation
Whole genome sequencing of Saccharomyces cerevisiae: from genotype to phenotype for improved metabolic engineering applications